China Keytruda Market: Revolutionizing Cancer Immunotherapy in the...

adicionou um novo artigo Iniciativas de Impacto

2026-09-28 05:54:46 -

China Keytruda Market: Revolutionizing Cancer Immunotherapy in the World's Largest Population

The China Keytruda Market was valued at USD 2,031.52 million in 2024 and is projected to grow to USD 5,299 million by 2035, registering a CAGR of 9.11% during the forecast period. This significant growth trajectory reflects the essential role of Keytruda in addressing the demand for effective cancer immunotherapy, improved patient outcomes, and innovative treatment options across China's vast...

0 Comentários 0 Compartilhamentos 0 Anterior